UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 82.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,346,698 shares of the real estate investment trust's stock after selling 6,335,740 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.19% of Healthpeak Properties worth $27,298,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. lifted its position in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after acquiring an additional 4,056,931 shares during the period. Vert Asset Management LLC lifted its holdings in shares of Healthpeak Properties by 11.1% in the 4th quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust's stock valued at $6,167,000 after buying an additional 30,461 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Healthpeak Properties by 25.7% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust's stock valued at $2,213,000 after buying an additional 22,300 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Healthpeak Properties by 16.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock valued at $2,217,000 after buying an additional 15,753 shares during the period. Finally, Sterling Capital Management LLC lifted its holdings in shares of Healthpeak Properties by 22.4% in the 4th quarter. Sterling Capital Management LLC now owns 80,157 shares of the real estate investment trust's stock valued at $1,625,000 after buying an additional 14,689 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Price Performance
NYSE:DOC traded up $0.12 during trading hours on Thursday, hitting $17.53. 6,771,698 shares of the stock were exchanged, compared to its average volume of 5,120,996. Healthpeak Properties, Inc. has a 52-week low of $16.64 and a 52-week high of $23.26. The firm's fifty day moving average price is $18.28 and its 200 day moving average price is $19.79. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market cap of $12.18 billion, a P/E ratio of 50.07, a P/E/G ratio of 2.17 and a beta of 1.05.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same period in the previous year, the business earned $0.45 EPS. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently announced a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's dividend payout ratio is currently 305.00%.
Insider Transactions at Healthpeak Properties
In other news, CEO Scott M. Brinker purchased 2,750 shares of the firm's stock in a transaction on Friday, May 9th. The shares were bought at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the purchase, the chief executive officer now directly owns 204,613 shares of the company's stock, valued at approximately $3,558,220.07. This trade represents a 1.36% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Tommy G. Thompson purchased 5,777 shares of the firm's stock in a transaction on Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the purchase, the director now directly owns 144,290 shares of the company's stock, valued at $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 29,764 shares of company stock worth $521,909 in the last ninety days. Insiders own 0.23% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on DOC. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Robert W. Baird cut their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Argus restated a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Evercore ISI cut their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Scotiabank cut their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.45.
View Our Latest Analysis on Healthpeak Properties
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
